(Inflamm Res[TA])
4,393 results
  • From copper imbalance to immunometabolic remodeling: cuproptosis-related vulnerability and therapeutic hypotheses in autoimmune diseases. [Review]
    Inflamm Res. 2026 Jul 11; 75(1).Shao Y, Zhang RF, … Song ZJIR
  • CONCLUSIONS: Current research on cuproptosis in AIDs is largely correlative, bioinformatic, or model dependent, and is insufficient to confirm canonical cuproptosis as a primary pathogenic mechanism in AIDs. Cuproptosis should be regarded as a conditional and hypothesis-generating framework. Future studies should adopt a rigorous evidence hierarchy, optimize diseaserelevant model selection, and validate its pathophysiological significance through direct biochemical assays. The clinical translation of copper-targeted therapeutic strategies still requires substantial foundational and clinical research support.
  • Integrative multi-omics identifies CYP1B1 as a candidate molecular link between toxicant exposure and ferroptosis-related epithelial stress in COPD. [Journal Article]
    Inflamm Res. 2026 Jul 11; 75(1).Liu L, Jiang M, … Liu SIR
  • CONCLUSIONS: Integrative multi-omics and experimental analyses identified CYP1B1 as a candidate COPD-associated epithelial stress biomarker linked to ferroptosis-related signatures in airway secretory cell populations. The findings suggest a potential association between cigarette-smoke-induced CYP1B1 upregulation, lipid peroxidation-related epithelial injury, and epithelial remodeling in COPD. However, CYP1B1 should be considered an exploratory biomarker and putative mechanistic node rather than a validated diagnostic tool or therapeutic target at this stage. Further studies using larger clinically annotated cohorts, smoking-adjusted analyses, cell-type-specific perturbation, ferroptosis rescue experiments, and pharmacological validation are needed.